Published in Health Business Week, March 9th, 2007
Prior to this clinical stage, AndroScience won the Third Place Award (out of >900 posters) for its presentation entitled "Androgen Receptor Degradation (ARD) Enhancer: A Potential Application for Topical Treatment of Acne Vulgaris" at the Annual Meeting of American Academy of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.